Skip to main content
. 2024 Jul 4;14:15444. doi: 10.1038/s41598-024-65835-2

Table 1.

Characteristics of study participants: newly diagnosed lung cancer (LC) patients and patients with chronic obstructive pulmonary disease (COPD).

Discovery and verification set (n = 100) Validation set (n = 55)
LC patients (n = 50) COPD patients (n = 50) LC patients (n = 28) COPD patients (n = 27)
Current smokers Former smokers Current smokers Former smokers Current smokers Former smokers Current smokers Former smokers
N 25 25 25 25 13 15 10 17
Age, years Mean ± SD 63 ± 6.4 67 ± 5.2 61 ± 5.8 69 ± 8.3 64 ± 6.6 66 ± 3.4 63 ± 8.2 67.8 ± 10.4
Median 62 68 61 70 65 65 63 66
Sex, n Female 7 8 8 7 3 6 4 2
Male 18 17 17 18 10 9 6 15
BMI, kg/m2 Mean ± SD 25.2 ± 4.5 26.9 ± 3.9 28.2 ± 6.8 26.4 ± 4.9 24.9 ± 4.0 26.0 ± 5.1 24.7 ± 9.1 30.4 ± 6.2
Median 25.6 27.5 27.3 26.3 25.4 25.2 22.1 32.3
Smoking intensity, packyears Mean ± SD 41.7 ± 13.0 29.3 ± 18.9 39.5 ± 13.4 30.3 ± 13.5 38.1 ± 15.5 24.9 ± 8.7 42.8 ± 20.4 46.2 ± 16.1
Median 40 27 40 32 40 20 43 48
Smoking cessation time, years 2–5 years n/a 9 n/a 6 n/a 5 n/a 4
6–10 years n/a 5 n/a 6 n/a 1 n/a 3
11–15 years n/a 8 n/a 6 n/a 5 n/a 5
 > 15 years n/a 3 n/a 7 n/a 4 n/a 5

Clinical stage according to TNM classification,

7th ed, n

I 13 11 n/a n/a 6 6 n/a n/a
II 8 6 n/a n/a 4 5 n/a n/a
III 4 8 n/a n/a 1 4 n/a n/a
Unspecified n/a n/a 2 n/a n/a
Histology, n Adenocarcinoma 11 10 n/a n/a 5 8 n/a n/a
Squamous-cell carcinoma 12 15 n/a n/a 7 7 n/a n/a
Other or unspecified 2 n/a n/a 1 n/a n/a